| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN 38105
Many receptor systems use receptor clustering for transmembrane signaling. In this study, we show that acid sphingomyelinase (ASM) is essential for the clustering of CD40. Stimulation of lymphocytes via CD40 ligation results in ASM translocation from intracellular stores, most likely vesicles, into distinct membrane domains on the extracellular surface of the plasma membrane. Surface ASM initiates a release of extracellularly oriented ceramide, which in turn mediates CD40 clustering in sphingolipid-rich membrane domains. ASM, ceramide, and CD40 colocalize in the cap-like structure of stimulated cells. Deficiency of ASM, destruction of sphingolipid-rich rafts, or neutralization of surface ceramide prevents CD40 clustering and CD40-initiated cell signaling. These findings indicate that the ASM-mediated release of ceramide and/or metabolites of ceramide regulate clustering of CD40, which seems to be a prerequisite for cellular activation via CD40.
This article has been cited by other articles:
|
|
 |
|
  J. A. Rotolo, B. Stancevic, S. X. Lu, J. Zhang, D. Suh, C. G. King, L. W. Kappel, G. F. Murphy, C. Liu, Z. Fuks, et al. Cytolytic T cells induce ceramide-rich platforms in target cell membranes to initiate graft-versus-host disease Blood, October 22, 2009; 114(17): 3693 - 3706. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Li, Y. Li, M. Chakraborty, Y. Fan, H. H. Bui, D. A. Peake, M.-S. Kuo, X. Xiao, G. Cao, and X.-C. Jiang Liver-specific Deficiency of Serine Palmitoyltransferase Subunit 2 Decreases Plasma Sphingomyelin and Increases Apolipoprotein E Levels J. Biol. Chem., September 25, 2009; 284(39): 27010 - 27019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Uhlig and E. Gulbins Sphingolipids in the Lungs Am. J. Respir. Crit. Care Med., December 1, 2008; 178(11): 1100 - 1114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Reyes-Moreno, E. Sharif-Askari, J. Girouard, C. Leveille, M. Jundi, A. Akoum, R. Lapointe, A. Darveau, and W. Mourad Requirement of Oxidation-dependent CD40 Homodimers for CD154/CD40 Bidirectional Signaling J. Biol. Chem., July 6, 2007; 282(27): 19473 - 19480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Pozo, M. Vales-Gomez, N. Mavaddat, S. C. Williamson, S. E. Chisholm, and H. Reyburn CD161 (Human NKR-P1A) Signaling in NK Cells Involves the Activation of Acid Sphingomyelinase J. Immunol., February 15, 2006; 176(4): 2397 - 2406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Gulbins and P. L. Li Physiological and pathophysiological aspects of ceramide Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R11 - R26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Y. Zhang, F. Yi, G. Zhang, E. Gulbins, and P.-L. Li Lipid Raft Clustering and Redox Signaling Platform Formation in Coronary Arterial Endothelial Cells Hypertension, January 1, 2006; 47(1): 74 - 80. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wu, Y. Cheng, B. A. G. Jonsson, A. Nilsson, and R.-D. Duan Acid sphingomyelinase is induced by butyrate but does not initiate the anticancer effect of butyrate in HT29 and HepG2 cells J. Lipid Res., September 1, 2005; 46(9): 1944 - 1952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Grassme, A. Riehle, B. Wilker, and E. Gulbins Rhinoviruses Infect Human Epithelial Cells via Ceramide-enriched Membrane Platforms J. Biol. Chem., July 15, 2005; 280(28): 26256 - 26262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Rotolo, J. Zhang, M. Donepudi, H. Lee, Z. Fuks, and R. Kolesnick Caspase-dependent and -independent Activation of Acid Sphingomyelinase Signaling J. Biol. Chem., July 15, 2005; 280(28): 26425 - 26434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Lang, D. S. Kempe, V. Tanneur, K. Eisele, B. A. Klarl, S. Myssina, V. Jendrossek, S. Ishii, T. Shimizu, M. Waidmann, et al. Stimulation of erythrocyte ceramide formation by platelet-activating factor J. Cell Sci., March 15, 2005; 118(6): 1233 - 1243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Czarny and J. E. Schnitzer Neutral sphingomyelinase inhibitor scyphostatin prevents and ceramide mimics mechanotransduction in vascular endothelium Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1344 - H1352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Abdel Shakor, K. Kwiatkowska, and A. Sobota Cell Surface Ceramide Generation Precedes and Controls Fc{gamma}RII Clustering and Phosphorylation in Rafts J. Biol. Chem., August 27, 2004; 279(35): 36778 - 36787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Bezombes, S. Grazide, C. Garret, C. Fabre, A. Quillet-Mary, S. Muller, J.-P. Jaffrezou, and G. Laurent Rituximab antiproliferative effect in B-lymphoma cells is associated with acid-sphingomyelinase activation in raft microdomains Blood, August 15, 2004; 104(4): 1166 - 1173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lacour, A. Hammann, S. Grazide, D. Lagadic-Gossmann, A. Athias, O. Sergent, G. Laurent, P. Gambert, E. Solary, and M.-T. Dimanche-Boitrel Cisplatin-Induced CD95 Redistribution into Membrane Lipid Rafts of HT29 Human Colon Cancer Cells Cancer Res., May 15, 2004; 64(10): 3593 - 3598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gupta, R. Natarajan, S. G. Payne, E. J. Studer, S. Spiegel, P. Dent, and P. B. Hylemon Deoxycholic Acid Activates the c-Jun N-terminal Kinase Pathway via FAS Receptor Activation in Primary Hepatocytes: ROLE OF ACIDIC SPHINGOMYELINASE-MEDIATED CERAMIDE GENERATION IN FAS RECEPTOR ACTIVATION J. Biol. Chem., February 13, 2004; 279(7): 5821 - 5828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-X. Contreras, A.-V. Villar, A. Alonso, R. N. Kolesnick, and F. M. Goni Sphingomyelinase Activity Causes Transbilayer Lipid Translocation in Model and Cell Membranes J. Biol. Chem., September 26, 2003; 278(39): 37169 - 37174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Contin, V. Pitard, T. Itai, S. Nagata, J.-F. Moreau, and J. Dechanet-Merville Membrane-anchored CD40 Is Processed by the Tumor Necrosis Factor-{alpha}-converting Enzyme: IMPLICATIONS FOR CD40 SIGNALING J. Biol. Chem., August 29, 2003; 278(35): 32801 - 32809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Drobnik, G. Liebisch, F.-X. Audebert, D. Frohlich, T. Gluck, P. Vogel, G. Rothe, and G. Schmitz Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients J. Lipid Res., April 1, 2003; 44(4): 754 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Krippner-Heidenreich, F. Tubing, S. Bryde, S. Willi, G. Zimmermann, and P. Scheurich Control of Receptor-induced Signaling Complex Formation by the Kinetics of Ligand/Receptor Interaction J. Biol. Chem., November 8, 2002; 277(46): 44155 - 44163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Grassme, J. Bock, J. Kun, and E. Gulbins Clustering of CD40 Ligand Is Required to Form a Functional Contact with CD40 J. Biol. Chem., August 9, 2002; 277(33): 30289 - 30299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Ayllon, A. Fleischer, X. Cayla, A. Garcia, and A. Rebollo Segregation of Bad from Lipid Rafts Is Implicated in the Induction of Apoptosis J. Immunol., April 1, 2002; 168(7): 3387 - 3393. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
